United States  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

Purdue Pharma

American phamaceutical company

Purdue Pharma    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Purdue Pharma: American phamaceutical company
Purdue Pharma L.P. is a privately held pharmaceutical company owned principally by descendants of Mortimer and Raymond Sackler. In 2007, it paid out one of the largest fines ever levied against a pharmaceutical firm for mislabeling its product OxyContin, and three executives were found guilty of criminal charges. Although the company shifted its focus to abuse-deterrent formulations, Purdue continued to market and sell opioids, and continued to be involved in lawsuits around the opioid epidemic in the United States. Purdue filed for Chapter 11 bankruptcy protection on September 15, 2019 in New York.

0
shares
ShareTweetSavePostSend
 

OxyContin maker Purdue gets brief shield from litigation

OxyContin maker Purdue Pharma LP won a court order on Friday briefly pausing the sprawling opioid litigation against the company so it can try to make headway on its proposed legal settlement that it..
Reuters - Published

Judge sees benefit in pausing lawsuits against OxyContin maker Purdue

A U.S. Bankruptcy Judge signaled support on Friday for a six-month pause to litigation led by 24 states against OxyContin maker Purdue Pharma LP to give the company time to settle thousands of lawsuits..
Reuters - Published

Videos for Purdue Pharma

OxyContin maker files for bankruptcy [Video]OxyContin maker files for bankruptcy

Purdue Pharma, the company behind OxyContin, filed for bankruptcy protection Sunday night (September 15), amid more than 2,600 lawsuits alleging the company helped fuel the deadly U.S. opioid epidemic...

Credit: Reuters Studio     Duration: 01:24Published

Purdue reaches tentative opioid settlement -sources [Video]Purdue reaches tentative opioid settlement -sources

OxyContin maker Purdue Pharma reached a tentative agreement with some plaintiffs to resolve widespread litigation over its alleged role in fueling the U.S. opioid crisis and plans to tussle with states..

Credit: Reuters Studio     Duration: 00:45Published

J&J ordered to pay $572 mln in Oklahoma opioid case [Video]J&J ordered to pay $572 mln in Oklahoma opioid case

An Oklahoma judge on Monday found Johnson & Johnson liable for fueling an opioid epidemic in the state by deceptively marketing painkillers, and ordered the drugmaker to pay damages of $572 million...

Credit: Reuters Studio     Duration: 01:19Published

Oklahoma AG tells J&J CEO to "get out his checkbook" [Video]Oklahoma AG tells J&J CEO to "get out his checkbook"

Oklahoma Attorney General Mike Hunter slammed Johnson & Johnson as the "kingpin behind the nation's ongoing opioid crisis" moments after a judge ruled against the drugmaker and ordered it to pay $572..

Credit: Reuters Studio     Duration: 01:04Published

Oklahoma judge to rule on J&J opioid case [Video]Oklahoma judge to rule on J&J opioid case

An Oklahoma judge will rule on Monday on whether Johnson & Johnson should be held liable in a lawsuit by the state's attorney general who argues the drugmaker should be forced to pay $17 billion for..

Credit: Reuters Studio     Duration: 01:46Published

 

Cracks in Purdue's proposed opioid settlement as Arizona backs out

The U.S. state of Arizona withdrew its support for a proposed nationwide opioid settlement with Purdue Pharma LP, saying the maker of OxyContin sought to "undermine material terms of the deal,"..
Reuters - Published

Sacklers reaped up to $13 billion from OxyContin maker, U.S. states say

OxyContin maker Purdue Pharma LP steered up to $13 billion in profits to the company's controlling Sackler family, according to U.S. states opposing efforts to halt lawsuits alleging the company and..
Reuters - Published

U.S. states fight back against Purdue's bid to halt opioid lawsuits

U.S. state officials are due on Friday to launch a counterattack against OxyContin maker Purdue Pharma LP over its attempt to shield the company and its controlling Sackler family from thousands of..
Reuters - Published

Colleges got $60M-plus from OxyContin family

Prestigious universities around the world have accepted at least $60 million from the family that owns Purdue Pharma over the past five years.. (Oct. 3)  
USATODAY.com - Published

Purdue Pharma to stay in business as it pursues bankruptcy protection

Lawyers for the pharmaceutical company secured permission to maintain business as usual — paying employees and vendors, supplying pills to distributors and keeping current on taxes and insurance
CBS News - Published

Purdue bankruptcy hearing gets underway

A judge heard arguments to decide whether lawsuits against members of the Sackler family that owns Purdue Pharma can go ahead with the company seeking bankruptcy protection. (Sept. 17)  
USATODAY.com - Published

AP Top Stories 5P

Here are the top stories for Tuesday, September 17th: Cokie Roberts dies; Purdue Pharma in bankruptcy court; R Kelly in court; New York skyscraper hits 1550 feet.  
USATODAY.com - Published

David Sackler defends family and Purdue Pharma

Vanity Fair contributing editor Bethany McClean joined CBSN to discuss her reporting on Purdue Pharma and its involvement in the opioid epidemic. She interviewed David Sackler, who says his family did..
CBS News - Published

Purdue Pharma files for bankruptcy amid numerous lawsuits over opioid epidemic

Purdue Pharma, the company that made billions selling the prescription painkiller OxyContin, filed for bankruptcy late Sunday. The move came days after Purdue reached a tentative settlement with many..
CBS News - Published

Purdue Pharma files for bankruptcy. Here's what it means

Purdue Pharma is framing its bankruptcy filing as an opportunity to cut red tape and provide billions in settlement cash to curb the opioid crisis.
USATODAY.com - Published Also reported by •CBS News

Even with bankruptcy, Purdue Pharma may not be off hook

Some states plan to object to a settlement in bankruptcy court and may pursue lawsuits against the Sackler family
CBS News - Published

Your Monday Briefing

Iran, Purdue Pharma, Ric Ocasek: Here’s what you need to know.
NYTimes.com - Published

OxyContin maker Purdue Pharma files for bankruptcy as part of opioids settlement

OxyContin maker Purdue Pharma filed for bankruptcy protection Sunday, days after reaching a tentative settlement with many state and local governments
USATODAY.com - Published

New York Uncovers $1 Billion in Sackler Family Wire Transfers

In a court filing, the state attorney general’s office says that it has found new account transfers by family members who own Purdue Pharma, the maker of opioids.
NYTimes.com - Published

Eye Opener: The Trump administration moves to ban most flavored e-cigarettes

President Trump proposes a ban on most flavored vaping products. Also, 23 states have reached a tentative settlement with OxyContin maker Purdue Pharma over the nation’s opioid crisis. All that and..
CBS News - Published

Purdue settlement falls short for some in Ohio

Ohio has been hit hard by the opioid crisis and residents in Barberton say the settlement with Purdue Pharma will do little to alleviate the opioid epidemic. (Sept. 11)  
USATODAY.com - Published

Purdue Pharma reaches tentative deal to settle opioid lawsuits

Arizona's attorney general said the tentative deal was the quickest way to get relief for communities devastated by the opioid epidemic.
CBS News - Published

OxyContin maker agrees to tentative settlement for opioid case, attorneys say

Purdue Pharma will reportedly pay up to $12 billion over time and the Sackler family will give up control of the company, sources say.
USATODAY.com - Published

If OxyContin-maker Purdue Pharma files for bankruptcy plaintiffs could see smaller payouts

A government source tells CBS News the maker of oxycontin could file for bankruptcy as early as Wednesday. Purdue Pharma and its owners, members of the Sackler family, have been negotiating a potential..
CBS News - Published

Sackler family could pay billions to settle opioid lawsuits

The billionaire Sackler family may be willing to pay up, to settle thousands of lawsuits stemming from the opioid crisis. The proposed settlement comes amid speculation that the family's company,..
CBS News - Published

U.S. judge allows public nuisance claim in opioid trial

The U.S. judge overseeing nationwide litigation concerning the opioid epidemic on Monday rejected Purdue Pharma LP's effort to dismiss claims that its activities caused a public nuisance.
Reuters - Published

U.S. judge denies bid to dismiss claim opioids are a public nuisance

The U.S. judge overseeing nationwide litigation concerning the opioid crisis on Monday rejected Purdue Pharma LP's effort to dismiss claims that its activities caused a public nuisance.
Reuters - Published

Sackler family could keep fortune in proposed Purdue opioids settlement

Washington Post reporter Lenny Bernstein joins CBSN to discuss his reporting on a proposed Purdue Pharma settlement could leave the Sackler family with most of their personal fortune.
CBS News - Published

Purdue Pharma prepping for a bankruptcy, report says

Lawyers for opioid peddler Purdue Pharma have documents in works for a Chapter 11 bankruptcy filing, Reuters reports
CBS News - Published

Purdue University: We're not Purdue Pharma, OK?

Same name, different Purdue: Indiana school finds it must distance itself from pharma company tied to opioid crisis
CBS News - Published

Sacklers vs. States: Settlement Talks Stumble Over Foreign Business

The Sackler family is willing to give up Purdue Pharma to settle all claims related to the opioid crisis, but is resisting a quick sale of its overseas drug company.
NYTimes.com - Published

Eye Opener: The president signs an emergency declaration for Puerto Rico

Puerto Rico braces for Tropical Storm Dorian. Also, Purdue Pharma is offering $10 to 12 billion to settle more than 2,000 lawsuits accusing them of fueling the opioid crisis. All that and all that..
CBS News - Published

Ex-Purdue Pharma head defends OxyContin marketing in video

The video comes from a deposition that was part of a 2015 lawsuit against the company by the state of Kentucky
CBS News - Published

Purdue Pharma offering billions to settle opioid crisis lawsuits

CBS News has learned Purdue Pharma, the maker of oxycontin is offering to pay billions of dollars to settle thousands of lawsuits stemming from the opioid crisis. Newly obtained video also shows the..
CBS News - Published Also reported by •Reuters

Purdue Pharma opioids suits talks accelerating, plaintiffs say

Settlement negotiations cover 2,000 lawsuits against the OxyContin maker and others in the industry; one report says it's made offer of up to $12B
CBS News - Published

Purdue Pharma offers opioid settlement

CBS News has learned Purdue Pharma, the maker of OxyContin, has offered $5-6 billion to settle thousands of claims. It is unclear how much Purdue's owners, the Sackler family, would have to pay.
CBS News - Published

Purdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid lawsuits: sources

OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the company for $10 billion to $12 billion, two people familiar..
Reuters - Published

Opioid drugmaker Purdue Pharma offers $10-12 billion to settle opioid claims: NBC News

OxyContin maker Purdue Pharma and its owners, the Sackler family, are offering to settle more than 2,000 lawsuits against the company for $10 billion to $12 billion, NBC News reported on Tuesday,..
Reuters - Published

Judge orders Johnson & Johnson to pay $572 million for role in opioid crisis

The state previously settled with OxyContin-maker Purdue Pharma and Israel's Teva Pharmaceutical for a total of more than $350 million.
USATODAY.com - Published

No Pre-Reading, No Rehearsing: How ‘The Weekly’ Kept Its Recreation of Historic Opioid Testimony Authentic

The Times TV show’s producer/director shares the challenges and rewards of bringing to life witness testimony against Purdue Pharma in a way that stayed true to our journalistic principles.
NYTimes.com - Published

New York Subpoenas Banks, Financial Advisers for Sackler Records

The state claims that the Purdue Pharma owners transferred billions of dollars from the company and hid them in offshore partnerships and other entities.
NYTimes.com - Published

Arizona Files Novel Lawsuit in Supreme Court Over Opioid Crisis

The suit asks the justices to order the Sackler family to return billions said to have been looted from their company, Purdue Pharma
NYTimes.com - Published

Groups cut ties with Sackler family over OxyContin lawsuits

Museums and universities are cutting ties with the Sackler family amid lawsuits against them and the company they run, Purdue Pharma. They're accused of engaging in aggressive marketing tactics for the..
CBS News - Published

'We will hold them accountable': 48 states sue OxyContin maker alleging deceptive marketing

California, Hawaii, Maine and the District of Columbia filed lawsuits against OxyContin producer Purdue Pharma for deceptive marketing.
USATODAY.com - Published

Oklahoma Faces Off Against J & J in First Trial of an Opioid Maker

With Purdue Pharma and Teva settling the case, the state sought to hold J & J responsible for the broader opioid crisis. The company argued that it operated responsibly and lawfully.
NYTimes.com - Published

First Opioid Trial Takes Aim at J & J

Having settled with Purdue Pharma and Teva, Oklahoma will now try to blame Johnson & Johnson for its opioid disaster. Nearly 1,900 lawsuits remain nationwide.
NYTimes.com - Published

McKinsey, JPMorgan Chase drop Purdue Pharma amid opioid scrutiny

Companies are distancing themselves from the Oxycontin maker and its founding family amid thousands of lawsuits
CBS News - Published

OxyContin maker denies "stunningly overbroad" claims from states

45 states and about 2,000 local and tribal governments now have recent legal action against Purdue Pharma
CBS News - Published

You Might Like


 Page 1  〉 
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.